KMID : 0357920130470060541
|
|
Korean Journal of Pathology 2013 Volume.47 No. 6 p.541 ~ p.548
|
|
Immunohistochemical Classification of Primary and Secondary Glioblastomas
|
|
Lee Kyu-Sang
Choe Ghee-Young Nam Kyung-Han Seo An-Na Yun Su-Mi Kim Kyung-Ju Cho Hwa-Jin Park Sung-Hye
|
|
Abstract
|
|
|
Background: Glioblastomas may develop de novo (primary glioblastomas, P-GBLs) or through progression from lower-grade astrocytomas (secondary glioblastomas, S-GBLs). The aim of this study was to compare the immunohistochemical classification of glioblastomas with clinically determined P-GBLs and S-GBLs to identify the best combination of antibodies for immunohistochemical classification.
Methods: We evaluated the immunohistochemical expression of epidermal growth factor receptor (EGFR), p53, and isocitrate dehydrogenase 1 (IDH-1) in 150 glioblastoma cases.
Results: According to clinical history, the glioblastomas analyzed in this study consisted of 146 P-GBLs and 4 S-GBLs. Immunohistochemical expression of EGFR, p53, and IDH-1 was observed in 62.6%, 49.3%, and 11.1%, respectively. Immunohistochemical profiles of EGFR(+)/ p53(?), IDH-1(?)/EGFR(+)/p53(?), and EGFR(?)/p53(+) were noted in 41.3%, 40.2%, and 28.7%, respectively. Expression of IDH-1 and EGFR(?)/p53(+) was positively correlated with young age. The typical immunohistochemical features of S-GBLs comprised IDH-1(+)/EGFR(?)/p53(+), and were noted in 3.6% of clinically P-GBLs. The combination of IDH-1(?) or EGFR(+) was the best set of immunohistochemical stains for identifying P-GBLs, whereas the combination of IDH-1(+) and EGFR(?) was best for identifying S-GBLs.
Conclusions: We recommend a combination of IDH-1 and EGFR for immunohistochemical classification of glioblastomas. We expect our results to be useful for determining treatment strategies for glioblastoma patients.
|
|
KEYWORD
|
|
Glioblastoma, Immunohistochemistry, IDH1 protein, human, Genes, erbB-1, Genes, p53
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|